SCHEMBL20034142

SCHEMBL20034142

O=C(O)c1ccc(-c2nc3ccc(OC(=O)c4ccc5nc(-c6ccccc6)[nH]c5c4)cc3[nH]2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK2 O96017 14/20 0.71
▸ KDM4E B2RXH2 2/20 0.60
▸ ALDH1A1 P00352 2/20 0.60
▸ HPGD P15428 2/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ NR4A2 P43354 1/20 0.59
▸ MMP2 P08253 1/20 0.59
▸ MMP9 P14780 1/20 0.59
▸ MMP8 P22894 1/20 0.59
▸ MMP13 P45452 1/20 0.59
▸ HDAC3 O15379 1/20 0.59
▸ HDAC1 Q13547 1/20 0.59
▸ HDAC8 Q9BY41 1/20 0.59
▸ HDAC6 Q9UBN7 1/20 0.59
▸ NPC1 O15118 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ NFKB1 P19838 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ NFKB2 Q00653 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3178116 0.84 CHEK2 (0.78) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL2318980 0.83 CHEK2 (1.00) CHEK2NR4A2
SCHEMBL5219768 0.82 NR4A2 (0.83) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL6125993 0.82 CHEK2 (0.80) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL20982644 0.81 NR4A2 (0.86) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL2617479 0.80 KDM4E (0.71) CHEK2KDM4EALDH1A1HPGDMMP2
SCHEMBL20982511 0.79 MMP2 (0.78) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL1662761 0.79 CHEK2 (0.93) CHEK2KDM4EALDH1A1HPGDNR4A2
SCHEMBL5675969 0.79 CHEK2 (0.81) CHEK2KDM4EALDH1A1HPGDKMT2A
SCHEMBL27765862 0.78 CHEK2 (0.78) CHEK2ALDH1A1HPGDKMT2ANR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938243-B2 Compounds for affinity chromatography and for extending the half-life of a therapeutic agent GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-04-10 — — US disclosed
Send feedback